St. Jude Medical Plan to Acquire Spinal Modulation for US$ 215 Million
St. Jude Medical has announced that it has exercised the companys exclusive option to acquire Spinal Modulation, Inc., developer of […]
Say something
Saturday
May
Upcoming Event
St. Jude Medical has announced that it has exercised the companys exclusive option to acquire Spinal Modulation, Inc., developer of […]
The cardiology space has witnessed significant positive change in terms of new technology introduction says Kaustav Banerjee Kaustav Banerjee Country […]
St. Jude Medical, Inc., a global medical device company, announced that FORTUNE Magazine has named the company among the Worlds […]
St. Jude Medical, Inc., a global medical device company, announced the feasibility study results for the companys Porticoâ„ Transcatheter Aortic […]
St. Jude Medical, Inc., a global medical device company, announced the launch of the C7-XRâ„ Optical Coherence Tomography (OCT) Intravascular […]
St. Jude Medical, Inc. recently announced the first patient implant of an Eon Mini(TM), the world’s smallest, longest-lasting, rechargeable neurostimulator to treat chronic pain of the trunk or limbs and pain from failed back surgery.
St. Jude Medical, Inc., a global medical device company, announced the approval of the industry
J and J are now focusing on areas like diagnostics and stents for blood vessels outside the heart.
New products help ensure effective therapy delivery even for patients with high defibrillation thresholds, provide additional disease management monitors for heart failure patients or patients at risk for sudden cardiac arrest and can be implanted through a smaller incision due to reduced size.
St. Jude Medical, Inc. and GE Healthcare announced the worldwide commercial launch of the first fully integrated wireless solution for the measurement of Fractional Flow Reserve (FFR) in interventional Cathlabs.
Global market for Cardiac Defibrillators the market is forecast to exceed USD 16 billion by 2015. The market is primarily driven by the increasing incidence of cardiovascular diseases due to aging population and the increasing availability of emergency medical services worldover for the revival of sudden cardiac death victims.
[This article was published in the September 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
Business News
Intel Corp, the world’s biggest computer chip maker, recently won clearance from the US Food and Drug Administration to sell an in-home health monitoring system for patients with chronic conditions.
Enter your email to receive a weekly round-up of our best posts.